| Request a Trial to NEW EDGAR Online Pro Form 8-K for SALIX PHARMACEUTICALS LTD Results of Operations and Financial Condition, Other Events, Financial Item 2.02 Results of Operations and Financial Condition. On March 3, 2008, Salix Pharmaceuticals, Ltd. hosted a...
Friday March 7, 10:26 am ET By Jason Napodano, CFA Salix Pharmaceuticals Ltd. (NasdaqGS: SLXP - The company suffered a major setback in December 2007 when the FDA granted approval to three generic versions of lead product, Colazal. This is devastating news for Salix, as...
Shares of drug developer Salix Pharmaceuticals Ltd. fell to their lowest point in nearly five years Tuesday after the company said it swung to a fourth-quarter loss and its 2008 loss will be wider than Wall Street expects. ... 4q fall loss outlook salix shares The stock...
— Among the stock activity stories for Tuesday, March 4, from the AP Financial News: ... NEW YORK (AP) _ Clearwire Corp. shares slid Tuesday on the heels of its lackluster fourth-quarter results and disappointing revenue forecast, though the wireless Internet provider...
RALEIGH, N.C.----As a result of measurable success last year, Salix Pharmaceuticals, Ltd. is again partnering with Walgreens and the Colon Cancer Alliance to raise awareness and increase screenings for colorectal cancer during Colorectal Cancer Awareness Month.
Among the stock activity stories for Tuesday, March 4, from the AP Financial News: NEW YORK (AP) _ Clearwire Corp. shares slid Tuesday on the heels of its lackluster fourth-quarter results and disappointing revenue forecast, though the wireless Internet provider said it is still in active talks...
TradingMarkets ... Tuesday, March 04, 2008; Posted: 04:16 PM ) fell in after hours trading, down about 15 percent. The slip came as the company posted a fourth-quarter loss. The stock was down 95 cents just before 4:15 pm ET, sliding to $5.60. If pre-market losses hold,...
posted on: March 03, 2008 | about stocks: SLXP Executives Michael Freeman - Adam will begin the presentation with a review of the financial results for the fourth quarter and full year, 2008. Actual results might differ materially from those indicated by these...
| Request a Trial to NEW EDGAR Online Pro Form 8-K for SALIX PHARMACEUTICALS LTD Termination of a Material Definitive Agreement, Results of Operations a Item 1.02. On September 4, 2007, Salix Pharmaceuticals, Ltd. entered into a Co-Promotion Agreement with Eisai Inc. The...
Salix Pharmaceuticals, Ltd. engages in acquiring, developing, and commercializing prescription drugs used in the treatment of various gastrointestinal diseases in the United States. Its products include Colazal capsules for the treatment of ulcerative colitis; Xifaxan...